6 Dimensions Capital Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 24
Professionals
  • Investments
  • 63
  • Portfolio
  • 37
  • Exits
  • 21
Exits

6 Dimensions Capital General Information

Description

6 Dimensions Capital is a healthcare investment firm that focuses on the investments of healthcare startups or growth stage companies with operations in the U.S., Europe, China, Israel and other countries. It helps and enables entrepreneurs to create and grow innovative healthcare businesses for the benefits of patients worldwide. It was established in May, 2017 through the merger of Frontline BioVentures and WuXi Healthcare Ventures. The firm is headquartered in Shanghai, China with offices in Boston, San Francisco and Hong Kong.

Contact Information

Year Founded
2017
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • Block 17, No.999 Huanke Road
  • Pudong New District Post:201210
  • Shanghai
  • China
+86 021 0000 0000

6 Dimensions Capital Investments & Acquisitions (63)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
FogPharma 01-Mar-2021 Later Stage VC 00000 Drug Discovery Generating Revenue 00000000 0000 00.0
00000 000000000000 15-Jan-2021 00000 00000 00000 Biotechnology Generating Revenue/Not Profitable
0000 000000 01-Jan-2021 00000 00000 0000 Drug Discovery Generating Revenue
0000000000 (00000) 30-Dec-2020 00000 00000 0000 Therapeutic Devices Generating Revenue
000 000000000000 16-Dec-2020 00000 00000 0000 Drug Discovery Generating Revenue
0000000000 02-Dec-2020 00 000000000 0000 Therapeutic Devices Generating Revenue
0000000 000000 04-Jun-2020 00000 00000 000.00 Therapeutic Devices Generating Revenue
0000000000 06-May-2020 00000 00000 000.00 Clinics/Outpatient Services Generating Revenue
iTeos Therapeutics 01-Apr-2020 Later Stage VC 00000 Drug Discovery Pre-Clinical Trials
Halda Therapeutics 24-Jan-2020 Early Stage VC 000.00 Drug Discovery Startup
You’re viewing 10 of 63 investments and acquisitions. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

6 Dimensions Capital Exits (21)

Company Name Exit Date Exit Type Exit Size
Viela Bio 15-Mar-2021 Merger/Acquisition 00.000
0000 000000000000 21-Jan-2021 000000 0000000000 00000
0000000 08-Jan-2021 000 00000
000000 00000000000 21-Aug-2020 000 00000
0000 000000000000 29-Jul-2020 000000 0000000000 00000
00000 000000000000 24-Jul-2020 000 00000
0000000000 0000000 10-Jul-2020 000 00000
00000 000 29-May-2020 000000 0000000000 00000
Semma Therapeutics 10-Oct-2019 Merger/Acquisition 00000
Viela Bio 03-Oct-2019 IPO 00000
You’re viewing 10 of 21 exits. Get the full list »

6 Dimensions Capital Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore 6 Dimensions Capital‘s full profile, request access.

Request a free trial

6 Dimensions Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

6 Dimensions Capital Team (26)

Name Title Deals Funds Boards Office
Lianyong Chen Ph.D Co-Founding Partner & Chief Executive Officer 00 0 0 Shanghai, China
Christina Chung Chief Financial Officer Shanghai, China
Wei Li Ph.D Co-Founding Partner & Managing Partner 0 0 0 Shanghai, China
Ching Zhu Ph.D Managing Partner & Member of Investment & Management Team 0 0 0 Shanghai, China
Fay Xing Ph.D Venture Partner 0 0 0 Shanghai, China
You’re viewing 5 of 26 team members. Get the full list »

6 Dimensions Capital Co-Investors (167)

Name With Exits Lead Partner Series Industry
ARCH Venture Partners 8 0 0 Series chart Industry bar
Boyu Capital 0 0 0 Series chart Industry bar
Hillhouse Capital Group 0 0 0 Series chart Industry bar
WuXi Healthcare Ventures 0 0 Series chart Industry bar
RA Capital Management 0 0 Series chart Industry bar
You’re viewing 5 of 167 co-investors. Get the full list »